BlackRock Advisors’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$4.84M Sell
443,917
-295,126
-40% -$3.22M ﹤0.01% 1104
2016
Q3
$10.4M Sell
739,043
-3,668
-0.5% -$51.4K 0.01% 818
2016
Q2
$5.21M Buy
742,711
+11,278
+2% +$79.2K 0.01% 1063
2016
Q1
$4.71M Buy
731,433
+225,467
+45% +$1.45M ﹤0.01% 1096
2015
Q4
$16.4M Buy
505,966
+11,568
+2% +$375K 0.02% 609
2015
Q3
$13.2M Buy
494,398
+37,597
+8% +$1M 0.01% 653
2015
Q2
$22M Buy
456,801
+84,237
+23% +$4.05M 0.02% 491
2015
Q1
$22.7M Buy
372,564
+72,764
+24% +$4.43M 0.02% 504
2014
Q4
$15.5M Buy
299,800
+288,485
+2,550% +$14.9M 0.02% 639
2014
Q3
$498K Sell
11,315
-30,498
-73% -$1.34M ﹤0.01% 1956
2014
Q2
$1.09M Sell
41,813
-39,616
-49% -$1.04M ﹤0.01% 1405
2014
Q1
$2.13M Sell
81,429
-75,371
-48% -$1.97M ﹤0.01% 1144
2013
Q4
$2.66M Buy
156,800
+700
+0.4% +$11.9K ﹤0.01% 1084
2013
Q3
$3.35M Buy
+156,100
New +$3.35M ﹤0.01% 1046